THE HINDU BUSINESS LINE
Financial Daily
from THE HINDU group of publications

Friday, November 30, 2001

• AGRI-BUSINESS
• CORPORATE
• INDUSTRY
• LETTERS
• MACRO ECONOMY
• MARKETS
• NEWS
• OPINION
• VARIETY
• INFO-TECH
• CATALYST
• INVESTMENT WORLD
• MONEY & BANKING
• LOGISTICS

• PAGE ONE
• INDEX
• HOME

Markets | Next | Prev


Ranbaxy Labs: On strong turf

Ranbaxy Laboratories has strengthened its position in the US market following the approval of the generic Acetaminophen and Codeine Phosphate tablets.

The bigger Ranbaxys product basket is in the US, the better will the returns be. Therefore, the development augurs well from a long-term perspective. -- BL Research Bureau

Comment on this article to BLFeedback@thehindu.co.in

Send this article to Friends by E-Mail


Next: Positive trend in Reliance Petro
Prev: Diamond Cables: Big order, but....
Markets

Agri-Business | Corporate | Industry | Letters | Macro Economy | Markets | News | Opinion | Variety | Info-Tech | Catalyst | Investment World | Money & Banking | Logistics |

Page One | Index | Home


Copyright © 2001 The Hindu Business Line.

Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line.